Stock comparison
NEOGEN CORP is 1.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($2.54 B vs $2.35 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NEOG is larger
NEOGEN CORP is 1.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($2.54 B vs $2.35 B).
Market value leader
NEOG
NEOGEN CORP is 1.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($2.54 B vs $2.35 B).
Revenue leader
NEOG
NEOG: $894.66M vs CLDX: $1.54M.
Profit leader
CLDX
NEOG: -$1.09B vs CLDX: -$258.76M.
Margin leader
NEOG
NEOG: -122.1% vs CLDX: -16748.0% net margin.
| Metric | NEOG | CLDX |
|---|---|---|
| Market cap | $2.54 B | $2.35 B |
| US-listed rank | #1924 | #1978 |
| Revenue (latest FY) | $894.66M | $1.54M |
| Net income (latest FY) | -$1.09B | -$258.76M |
| Net margin | -122.1% | -16748.0% |
| P/E (trailing FY) | - | - |
| SEC filings | 1,894 | 1,266 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
NEOGEN CORP is 1.1x more valuable than Celldex Therapeutics, Inc. by market capitalization ($2.54 B vs $2.35 B).
In their latest fiscal years, NEOGEN CORP reported $894.66M in revenue while Celldex Therapeutics, Inc. reported $1.54M.
Full pages: NEOGEN CORP and Celldex Therapeutics, Inc., or browse the full rankings.